Samsung Q2 results 2025: Operating profit falls 56%, lowest since 2023 on chip business crisis
In the June quarter, the company's operating profit dropped by a sharper-than-expected 56 per cent, largely due to inventory write downs triggered by U.S. export restrictions on AI chips destined for China.
Samsung posted a preliminary operating profit of 4.6 trillion won ($3.3 billion) for the June quarter, marking its lowest since 2023 and falling short of analysts' expectations.
Revenue remained steady at 74 trillion won. A complete financial report, including net income and a breakdown by divisions, will be released later this month.
These underwhelming earnings reveal how South Korea's tech giant has lost ground in the AI memory chip space to SK Hynix Inc., particularly amid the surge in demand after ChatGPT's rise. SK Hynix and Micron Technology Inc. have taken the lead in supplying advanced high-bandwidth memory chips used alongside Nvidia's AI processors.
Meanwhile, Samsung's efforts to revive its loss-making chip foundry business are being hampered by ongoing U.S. restrictions on tech exports to China.
Samsung reported a decline in profit after its foundry division, which partially depends on demand from China, incurred a one-time inventory charge due to unsold AI chips.
The company also noted a drop in utilization rates, addressing the weaker-than-expected results in a rare statement. However, Samsung expects operating losses in its contract chipmaking segment to shrink in the second half of the year as demand slowly recovers.
Despite prevailing concerns, shares of Samsung Electronics edged up by 0.4%, compared to a 1.5 per cent rise in the benchmark KOSPI as of 0030 GMT. The company announced plans to repurchase shares worth 3.9 trillion won ($2.85 billion), as part of a 10 trillion won buyback program unveiled in November.
The company plans to release detailed results including a breakdown of earnings for each of its businesses on July 31.
(With inputs from agencies)
Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
They are core to one of the world's biggest pharma & life sciences firms
Merck'S GCC leaders: (From left) Harsha Arora, Anuprita Bhattacharya, and Suneela Thatte Anuprita Bhattacharya is the one in the middle in the picture above. She has reason to hold up that victory sign. She's the head of the India IT centre for Merck , one of the world's biggest life sciences and pharma companies, and her teams have delivered projects that have ensured the voices of the India teams are now heard intently in the global CIO's office. She's most proud of what she's done with the company's Milli-Q lab water purification system . This system is used in laboratories – like the ones that do our blood tests – to remove impurities, and where very high quality water is required. It's a critical requirement, and yet, traditionally, labs would often fail to replenish the consumables in these systems in time. Anuprita's team integrated an IoT-enabled smart system in the equipment that would not only alert the lab that they are running out of liquid/chemicals, but also put the item in the cart on the company's e-commerce site. All that the lab technician has to do is click to buy. 'The system estimates the level of liquid, estimates the time it takes to get the liquid, and triggers the reminder,' Anuprita says. They also created a visual aid that provides a step-wise guide to installing the systems containing the liquids, so that the lab did not have to wait for a service engineer. 'It saved at least 8-9 man days. Customers loved it,' Anuprita says. It was one of Merck's biggest product enhancement successes. Another big success was a chatbot that's now used across the organisation's different divisions. Merck is a nearly 360-year-old company, and Anuprita's team had to train the AI system with available data across these centuries. What's more, it's a German company, with stringent GDPR data privacy rules. 'We needed to ensure a very protected environment. And we did it all within 45 days of ChatGPT coming out,' Anuprita says. Leg up for life science Anuprita has a team of about 1,300 – out of the global data, digital and IT team of 2,800. In India, she has two colleagues – Harsha Arora and Suneela Thatte – who lead two other big Merck operations, and we met all of them together the other day in their Bengaluru campus. The Milli-Q product is actually part of the life sciences division that Harsha's 950-strong team primarily supports. The life science business provides a wide range of products and services for scientific research, biomanufacturing, and applied solutions. Harsha's team's job is to look at the competitive environment and identify promising new product areas. They then do feasibility studies. While the actual product development is done by global teams, often in Darmstadt in Germany, Harsha has a strategic marketing and innovation (SMI) team here that helps with the product launch. 'We have to meet the compliance regulations in every market. We classify products as dangerous or safe. We do the supply chain and planning. We do the content development for the products. We do the order management, customer query handling, preand post-sales support, and finally the collections from customers,' Harsha says. Helping drug development Suneela heads healthcare R&D in India. Merck's pharma is focused on oncology and neurology, but it also has products in cardiometabolic care and fertility. Suneela's team helps with every stage of the drug development process – starting with screening of molecules to identify effective candidates for a treatment, all the way to collating data about drugs, checking their safety, preparing documents for regulators. Suneela says her teams here write protocols for clinical trials that need to be submitted to regulators. Every protocol needs to be unique because each drug candidate is unique. Her teams analyse data from clinical trials and prepare reports for regulators. 'We have experienced writers in India who know exactly how to do these,' she says. Suneela also has teams that continuously monitor safety of all Merck drugs – those under research, as also those already in the market. 'We even have big teams to answer queries that regulators may have,' she says. AI is beginning to come into the workflows of both Suneela and Harsha. Sitting together with Anuprita's teams is making it much easier for them to create these solutions. AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Economic Times
an hour ago
- Economic Times
Gold rises as fresh Trump tariff threats dampen trade talk hopes
FUNDAMENTALS Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Gold edged higher on Wednesday as U.S. President Donald Trump's latest tariff threats dampened hopes for trade talks, but a stronger U.S. dollar and higher Treasury yields capped gains.* Spot gold rose 0.2% to $3,305.50 per ounce as of 0106 GMT. U.S. gold futures fell 0.1% to $3,314.50.* On Tuesday, Trump said he would impose a 50% tariff on imported copper and introduce long-threatened levies on semiconductors and pharmaceuticals.* The president sent tariff letters to 14 countries, including Japan and South Korea, on Monday, notifying them of higher tariffs from August 1.* The U.S. dollar index steadied after nearing a two-week high on Tuesday, while the yield on benchmark 10-year U.S. Treasury notes hovered near a three-week high.* Higher yield increases the opportunity cost of holding non-yielding bullion, while a weaker dollar makes it more affordable for holders of other currencies.* Meanwhile, recent national and global surveys of business executives highlighted the Federal Reserve's dilemma in determining if slowing growth or persistent inflation is the greater risk to the U.S. economy.* Business leaders expect this tension to persist as they plan price increases despite anticipating weaker revenue and demand, surveys of U.S. chief financial officers by the Fed and of global executives by Dun & Bradstreet revealed.* Americans' inflation outlook remained stable, with the New York Fed's latest survey showing one-year inflation estimates at 3%, down from 3.2% in May, while the three- and five-year expectations stayed at 3% and 2.6%, respectively.* The minutes of the Fed's last meeting, due later on the day, will be studied by investors for clues into potential interest rate cuts amid the central bank's wait-and-see stance.* Spot silver fell 0.4% at $36.63 per ounce, platinum held steady at $1,360.38 and palladium lost 0.3% to $1,107.41. DATA/EVENTS (GMT) 0130 China PPI, CPI YY June.
Time of India
an hour ago
- Time of India
Gold rises as fresh Trump tariff threats dampen trade talk hopes
Gold prices saw a slight increase. This happened because Donald Trump threatened new tariffs. These tariffs made people worry about trade talks. But, the dollar got stronger and Treasury yields went up. This stopped gold from going up too much. Investors are waiting for the Fed's meeting notes. These notes might give clues about interest rates. Tired of too many ads? Remove Ads FUNDAMENTALS Tired of too many ads? Remove Ads Gold edged higher on Wednesday as U.S. President Donald Trump's latest tariff threats dampened hopes for trade talks, but a stronger U.S. dollar and higher Treasury yields capped gains.* Spot gold rose 0.2% to $3,305.50 per ounce as of 0106 GMT. U.S. gold futures fell 0.1% to $3,314.50.* On Tuesday, Trump said he would impose a 50% tariff on imported copper and introduce long-threatened levies on semiconductors and pharmaceuticals.* The president sent tariff letters to 14 countries, including Japan and South Korea, on Monday, notifying them of higher tariffs from August 1.* The U.S. dollar index steadied after nearing a two-week high on Tuesday, while the yield on benchmark 10-year U.S. Treasury notes hovered near a three-week high.* Higher yield increases the opportunity cost of holding non-yielding bullion, while a weaker dollar makes it more affordable for holders of other currencies.* Meanwhile, recent national and global surveys of business executives highlighted the Federal Reserve's dilemma in determining if slowing growth or persistent inflation is the greater risk to the U.S. economy.* Business leaders expect this tension to persist as they plan price increases despite anticipating weaker revenue and demand, surveys of U.S. chief financial officers by the Fed and of global executives by Dun & Bradstreet revealed.* Americans' inflation outlook remained stable, with the New York Fed's latest survey showing one-year inflation estimates at 3%, down from 3.2% in May, while the three- and five-year expectations stayed at 3% and 2.6%, respectively.* The minutes of the Fed's last meeting, due later on the day, will be studied by investors for clues into potential interest rate cuts amid the central bank's wait-and-see stance.* Spot silver fell 0.4% at $36.63 per ounce, platinum held steady at $1,360.38 and palladium lost 0.3% to $1,107.41. DATA/EVENTS (GMT) 0130 China PPI, CPI YY June.
